Redeye initiates coverage of RaySearch, a software company offering treatment planning systems for radiotherapy clinics. We see good prospects for the company to extend its leadership position thanks to its resolute R&D-driven business model and strong value proposition. We expect increasing investor interest prompted by the quarterly reports (sales growth and EBIT margin expansion) and recognition of RaySearch’s high quality.
LÄS MER
